AtriCure, Inc. ATRC

ATRC Company Overview

AtriCure, Inc. is a U.S.-based medical device company focused on the treatment of atrial fibrillation (Afib) and related cardiac conditions through surgical ablation technologies, left atrial appendage management products, and pain management solutions. The company operates within the broader cardiovascular medical technology industry and primarily serves hospitals, cardiac surgeons, electrophysiologists, and healthcare systems. Its core revenue drivers include products used in open-heart surgeries, minimally invasive cardiac procedures, and post-operative pain management. AtriCure’s portfolio is centered on enabling physicians to treat Afib during concomitant cardiac surgery and standalone procedures, with a significant emphasis on clinical evidence and physician training.

The company was founded in 2000 and is headquartered in Mason, Ohio. AtriCure developed its market position through specialized cardiac ablation technologies and expanded into adjacent cardiovascular therapies through internal product development and acquisitions. Over time, the company broadened its offerings beyond ablation devices to include left atrial appendage exclusion systems and cryo-based nerve block technologies. AtriCure’s strategic positioning is supported by its focused specialization in Afib treatment, a substantial clinical evidence base, proprietary surgical technologies, and long-standing relationships with cardiac surgery programs globally.